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cristina civantos1, Wilbert Bitter  2 & María A. Llamas  1*
the extracytoplasmic function sigma factor σVrei of the human pathogen Pseudomonas aeruginosa 
promotes transcription of potential virulence determinants, including secretion systems and secreted 
proteins. its activity is modulated by the VreR anti-σ factor that inhibits the binding of σVrei to the 
RnA polymerase in the absence of a (still unknown) inducing signal. the vreI-vreR genes are expressed 
under inorganic phosphate (pi) starvation, a physiological condition often encountered in the host that 
increases P. aeruginosa pathogenicity. However, whether or not σVrei is active in vivo during infection 
and contributes to the pi starvation-induced virulence of this pathogen has not been analyzed yet. 
Using zebrafish embryos and a human alveolar basal epithelial cell line as P. aeruginosa hosts, we 
demonstrate in this work that σVrei is active during infection and that lack of σVrei considerably reduces 
the pi starvation-induced virulence of this pathogen. Surprisingly, lack of the σVrei inhibitor, the VreR 
anti-σ factor, also diminishes the virulence of P. aeruginosa. By transcriptomic analyses we show that 
VreR modulates gene expression not only in a σVrei-dependent but also in a σVrei-independent manner. 
this includes potential virulence determinants and transcriptional regulators that could be responsible 
for the reduced virulence of the ΔvreR mutant.
The pathogen Pseudomonas aeruginosa produces several life-threatening infections in humans, especially 
in immunocompromised, cancer, burn and cystic fibrosis patients and it is one of the primary reasons of 
hospital-acquired infections1–4. Importantly, antibiotic resistance among this pathogen has escalated globally 
over the past three decades and several outbreaks in hospitals have highlighted the need of controlling multi-drug 
resistant P. aeruginosa infection and spread5. Indeed, the World Health Organization has declared this bacterium 
the second priority pathogen demanding research and development of new treatment strategies. Therefore, there 
is an enormous research need to identify new molecular targets that permit the inhibition or elimination of this 
pathogen.
P. aeruginosa is highly metabolic versatile and harbors multiple virulence factors that enable this pathogen to 
infect essentially any mammalian tissue3,6. Central to the infectious process is the ability of the pathogen to adapt 
to changing environments and P. aeruginosa produces many global regulators and signal transduction systems 
that facilitate its adaptation7,8. Regulation of gene expression in bacteria occurs initially at the transcription initi-
ation level through the modulation of the affinity of the RNA polymerase (RNAP) for the DNA. Such affinity can 
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be modified through the replacement of the sigma (σ) subunit of the RNAP, which is the subunit responsible of 
promoter recognition and thus of the specificity of the RNAP, and/or by transcriptional regulators that enhance 
or repress RNAP binding and activity9. P. aeruginosa contains a plethora of these regulatory proteins, which often 
function in response to specific cues. Among them, sigma factors of the extracytoplasmic function sigma (σECF) 
factor family are important signal-responsive regulatory proteins in P. aeruginosa10,11. The σECF-mediated sign-
aling in this bacterium generally involves the function of an anti-σ factor10,11. Most P. aeruginosa anti-σ factors 
are single-pass transmembrane proteins that contain a cytosolic N-terminal domain that binds the σECF factor 
and occludes the RNAP binding determinants, and a periplasmic C-terminal domain required for signal trans-
duction. In response to a specific inducing signal, the anti-σ factor usually undergoes regulated proteolysis12–15, 
which leads to the release of an active σECF factor that binds to the RNAP and promotes transcription of the signal 
response genes.
P. aeruginosa contains between 19 and 21 σECF factors that cluster into nine different phylogenetic groups10. 
Most belong to the iron starvation (IS) group and are expressed in iron limiting conditions together with an 
anti-σ factor. Post-translational activation of IS σECF factors often occurs in response to the presence of an iron 
chelating compound (i.e. siderophores, heme/hemoglobin, iron-citrate) by a signal transduction cascade known 
as cell-surface signaling (CSS) that also involves an outer membrane-located TonB-dependent transducer 
(TBDT)10,16,17. IS σECF factors promote transcription of iron acquisition functions and regulate iron homeostasis, 
which are essential processes for P. aeruginosa to spread and colonize the host. Besides, several P. aeruginosa IS 
σECF factors stimulate the transcription of virulence determinants10,11,16. The second most abundant σECF group 
in P. aeruginosa is formed by the RpoE-like σECF factors. These σ factors are activated in response to cell envelope 
stress and trigger expression of functions that mitigate stress and maintain the integrity of the bacterial cell enve-
lope, thus ensuring pathogen survival10,11. While required during infection to cope with stresses produced by the 
host immune response (e.g. increased temperature, formation of oxygen reactive species or osmotic changes), P. 
aeruginosa stress-responsive σECF factors also promote expression of important virulence determinants (i.e. the 
exopolysaccharide alginate)10,11. The signaling cascade activating these σECF factors usually involves an anti-σ 
factor but not an outer membrane TBDT10,11.
The P. aeruginosa σVreI factor was initially classified within the IS group18. However, our recent analyses showed 
that expression of this σ factor is not regulated by iron, but by inorganic phosphate (Pi)19,20. This was in agreement 
with our initial observations showing that σVreI does not promote expression of iron acquisition functions21. σVreI 
is encoded by the vreAIR operon together with a CSS-like receptor protein (VreA) and a transmembrane anti-σ 
factor (VreR)19,21. While the anti-σ role of VreR has been demonstrated19, the function of VreA in the σVreI sign-
aling cascade, if any, is at present unknown. The N-terminal domain of VreA resembles that of CSS receptors21, 
which is the domain that interacts with the anti-σ factor upon signal recognition triggering activation of the CSS 
cascade and the IS σECF factor16. However, VreA lacks the C-terminal β-barrel domain of CSS receptors, which is 
the domain required for the uptake of the CSS ligand (i.e. siderophore, heme)21. We initially hypothesized that 
VreA could be involved in signaling but not in transport21; however, our recent analyses showed that, in vitro, 
VreA is not required for σVreI activation19. Transcription of the vreAIR operon takes place in Pi limited conditions 
and requires the phosphate transcriptional regulator PhoB19. Besides promoting vreI transcription, PhoB is also 
required for transcription of the σVreI regulon genes by recruiting the σVreI-RNAP complex to the promoter region 
of these genes19. Our earlier microarray analyses showed that the σVreI regulon includes several P. aeruginosa vir-
ulence determinants (Fig. 1)21. In accordance, constitutive activation of σVreI increases P. aeruginosa pathogenic-
ity21. Antibodies directed against secreted proteins of the σVreI regulon (i.e. PdtA, Fig. 1) are detected in the serum 
of P. aeruginosa infected patients21. Moreover, interaction of P. aeruginosa with host cells promotes transcription 
of σVreI regulon genes22,23. Together this suggests that transcription of the σVreI regulon occurs during infection 
and thus that σVreI is active in this condition. However, there is no direct proof yet demonstrating the activation 
of σVreI in vivo.
The aim of this work was to investigate whether the σVreI factor is active during infection. Moreover, because 
vreI is expressed under Pi starvation, a condition often encountered by pathogens in the host environment that is 
known to induce a virulent phenotype in P. aeruginosa24, we also aimed at determining the contribution of this σ 
factor to the Pi starvation-induced virulence of this pathogen. Using zebrafish embryos and a human respiratory 
epithelial cell line as P. aeruginosa hosts we show for the first time that σVreI is indeed activated during infection 
and that lack of the σVreI/VreR signaling proteins diminishes the Pi starvation-induced virulence of this pathogen.
Results
σVrei and VreR are required for P. aeruginosa virulence in zebrafish embryos. The virulence of P. 
aeruginosa was assayed using zebrafish (Danio rerio) embryos as host. P. aeruginosa is able to lethally infect zebraf-
ish embryos when the number of bacterial cells injected exceeds the phagocytic capacity of the embryo21,25,26. 
Because the expression of the vreAIR operon is induced under phosphate (Pi) starvation19,20, we first determined 
the effect of the Pi concentration in P. aeruginosa virulence. Thus, P. aeruginosa cells previously grown either in 
low or high Pi conditions were injected into the blood stream of one-day post-fertilization embryos to generate 
a systemic infection and embryo survival was monitored during five days. Survival of the embryos injected with 
PAO1 wild-type cells grown in low Pi was considerably lower than that of the embryos injected with PAO1 cells 
grown in high Pi conditions (P < 0.001) (Fig. 2A), which indicates that Pi starvation induces a P. aeruginosa 
virulent phenotype. The contribution of σVreI to this phenotype was determined using a null ΔvreI mutant. The 
virulence of this mutant was significantly lower than that of the PAO1 wild-type strain (P < 0.05) (Fig. 2B), which 
suggests that σVreI contributes to the low Pi-induced virulence of P. aeruginosa. Unexpectedly, a ∆vreR anti-σ fac-
tor mutant in which σVreI is highly active19 also showed attenuated virulence (P < 0.001) (Fig. 2B). This prompts 
that VreR may have more functions in P. aeruginosa than solely controlling σVreI activity or alternatively, that the 
timing and/or quantity of the σVreI response is crucial. In contrast, the absence of the CSS-like receptor protein 
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VreA did not have any effect on P. aeruginosa virulence, which was similar for the ΔvreA mutant and the PAO1 
strain (P = 0.35) (Fig. 2B). This suggests that this protein is not involved in the σVreI/VreR-mediated virulence of 
this bacterium.
σVrei and VreR are required for P. aeruginosa cytotoxicity. P. aeruginosa commonly affects the res-
piratory tract in humans. Therefore, we used the A549 human respiratory epithelial cell line as P. aeruginosa host. 
First we assayed the cytotoxicity of P. aeruginosa against the eukaryotic cells by determining A549 cell viability 
after co-incubation with the bacteria. Similar to the results obtained in the zebrafish embryos, we observed that 
growth of P. aeruginosa under Pi starvation slightly increases the bacterial cytotoxicity as the eukaryotic cells were 
more damaged by bacteria grown in low rather than in high Pi medium (Fig. 3A). Both σVreI and VreR contribute 
to this phenotype, because mutants lacking these proteins were significantly less efficient in damaging the A549 
cells than the PAO1 wild-type strain (Fig. 3A).
We also measured internalization of P. aeruginosa into A549 cells. Although considered an extracellular path-
ogen, P. aeruginosa is able to enter into non-phagocytic host cells such as epithelial cells27,28. The internalization 
efficiency of a given strain depends on several factors including the T3SS profile29,30. Strains that are more efficient 
in internalizing are less cytotoxic while less invasive strains kill the eukaryotic cells more rapidly. Therefore, there 
is an inverse correlation between internalization and cytotoxicity, and thus between internalization and acute vir-
ulence31. Upon P. aeruginosa infection of A549 cells, we observed a ∼3-fold increase in the internalization of the 
∆vreI and ∆vreR mutants as compared to the PAO1 wild-type strain (Fig. 3B). This is consistent with the lower 
Figure 1. Genetic organization of the σVreI regulon. Transcriptional organization of the vreAIR locus (black) 
and the downstream σVreI-regulated genes (colored). Block arrows represent the different genes, their relative 
sizes, and their transcriptional orientation, with the name of the gene or the PA number (http://www.
pseudomonas.com/) indicated below the arrow. The promoters and regulatory boxes identified within this locus 
are indicated19,20,62. Numbers indicate the fold-change in the expression of the gene in cells overproducing σVreI 
as determined earlier by microarray21. The hxc genes (dark green) encode a type II secretion system involved 
in the secretion of the low molecular weight alkaline phosphatase LapA (light green)62. pdtA and pdtB (blue) 
encode a functional two-partner secretion (TPS) system involved in P. aeruginosa virulence in the C. elegans 
model63. phdA (yellow) encodes a homologue of the prevent-host-death (Phd) protein family and is required 
for biofilm formation and eDNA release64. exbB2-exbD2-tonB4 genes (orange) encode a still uncharacterized 
putative TonB system. The function of the PA0696-PA0700 gene products (purple) is still unknown. PA0701 
(dark grey) encodes a putative LysR-like transcriptional regulator and PA0701a (light grey), which is not 
annotated in the PAO1 genome but it is in the P. aeruginosa PA14 genome, encodes a putative AraC-like 
transcriptional regulator.
Figure 2. Survival of zebrafish embryos upon infection with P. aeruginosa. One day post-fertilization embryos 
were injected with ∼1000 CFU of the P. aeruginosa PAO1 wild-type strain grown either in Pi-restricted or Pi-
sufficient conditions (A) or with the indicated PAO1 isogenic mutant grown under Pi starvation (B). Uninfected 
control (non-injected) is shown. Data represents the mean ± SD of four biologically independent replicates 
(N = 4) with 20 embryos/group in each replicate. P-values were calculated by log-rank (Mantel-Cox) test.
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cytotoxicity displayed by these mutants (Fig. 3A) and with the reduced capacity of these mutants to produce a 
systemic infection in zebrafish embryos (Fig. 2B).
VreR influences P. aeruginosa gene expression also in a σVrei-independent manner. The phe-
notype of the ΔvreR mutant, in which reduced instead of increased virulence was observed, prompted us to 
analyze gene expression in this mutant by RNA-seq. We compared the transcriptome of the P. aeruginosa PAO1 
wild-type strain with that of the ΔvreR mutant upon bacterial growth in Pi starvation, a condition known to 
induce vreR expression19. A total of forty-four transcripts were more abundant in the ΔvreR mutant than in the 
PAO1 wild-type strain, and nine were less abundant (including the vreR transcript) (Table 1). Increased expres-
sion of some of these genes in the ΔvreR mutant was confirmed by qRT-PCR (Fig. S1). Of the forty-four upregu-
lated genes, nineteen are located immediately downstream the vreAIR locus and most of them belong to the σVreI 
regulon previously identified by microarray of cells overproducing σVreI (Fig. 1)21. Other upregulated transcripts 
belong to genes located in different loci in the P. aeruginosa PAO1 genome (Table 1). These include genes encod-
ing metabolic and energy obtaining functions, transport, and several regulators of gene expression (Table 1).
We then wondered whether the increased expression of these genes in the ΔvreR mutant was due to σVreI, 
which is highly abundant and active in this mutant19. Therefore, we compared the relative expression of these 
genes in the ΔvreR mutant with that of the ΔvreI mutant in which vreR is also not produced due to a polar effect 
of the vreI deletion on the expression of the downstream vreR gene19 (referred as a ΔvreI vreR mutant in Fig. 4). 
A total of twenty-five genes were selected, eight known to belong to the σVreI regulon (Fig. 1). Indeed, these eight 
genes were expressed considerably less in the ΔvreI vreR mutant than in ΔvreR (Fig. 4). This shows that the 
Figure 3. P. aeruginosa infections in the A549 cell line. (A) A549 cell viability. The P. aeruginosa PAO1 wild-
type strain and the indicated isogenic mutant were grown in Pi-restricted (−) or Pi-sufficient (+) conditions 
prior to infection. Formazan production upon addition of the MTT tretazolium salt was determined 
spectrophotometrically at 620 nm. Uninfected cells (white bar) were used as control. (B) P. aeruginosa 
internalization into A549 cells. A549 cells were infected with the indicated P. aeruginosa strain previously 
grown in Pi-restricted conditions. Internalization is reported as the ratio between bacteria CFU inside (in) the 
A549 cells and CFU in the culture supernatant (out). In both panels data are means ± SD from three biological 
replicates (N = 3). P-values were calculated by unpaired two-tailed t-test as described in Materials and Methods 
and brackets indicate the comparison to which the P-value applies.









PA0141 — Polyphosphate kinase 2 (PPK2) (utilizes poly P to make GTP, which is needed for the synthesis of alginate)65 1,22 4.39 0.00587
PA0200 — Unknown function 2.56 8.52 0.00587
PA0677 hxcW Hxc T2SS62 4.26 8.46 0.00587
PA0680 hxcV Hxc T2SS62 2.92 9.54 0.00587
PA0681 hxcT Hxc T2SS62 3.99 12.30 0.00587
PA0682 hxcX Hxc T2SS62 4.15 11.79 0.00587
PA0683 hxcY Hxc T2SS62 4.69 5.17 0.00587
PA0685 hxcQ Hxc T2SS62 3.75 4.76 0.01063
PA0688 lapA Low-molecular-weight alkaline phosphatase A, secreted by the Hxc T2SS62 5.77 12.44 0.00587
PA0690 pdtA TPS partner A, large secreted exoprotein63 HIDATAe — —
PA0691 phdA Prevent-host-death protein A, involved in biofilm formation64 4.16 9.01 0.00587
PA0692 pdtB TPS partner B, outer membrane protein involved in pdtA secretion63 4.67 10.31 0.00587
PA0693 exbB2 ExbB proton channel 4.31 9.50 0.00587
PA0694 exbD2 ExbD protein family 4.46 13.55 0.00587
PA0695 tonB4 TonB energy protein 4.73 11.70 0.00587
PA0696 — Unknown function, putative outer membrane porin 4.22 9.71 0.00587
PA0697 — Unknown function, structural homology with channel-forming colicins 4.98 12.94 0.00587
PA0698 — Putative sensory transduction regulator of the YbjN protein family 4.91 13.18 0.00587
PA0699 — Probable peptidyl-prolyl cis-trans isomerase, PpiC-type 4.59 9.91 0.00587
PA0701 — Probable LysR-type transcriptional regulator 4.01 10.74 0.00587
PA0701a — Probable AraC-type transcriptional regulator 2.05 5.44 0.00587
PA1196 ddaR σ54 dependent transcriptional regulator, regulates methylarginine degradation66 1.23 4.32 0.01063
PA1414 — Unknown function 1.90 4.60 0.01063
PA1429 — Probable cation-transporting P-type ATPase 1.53 4.30 0.00587
PA1546 hemN Oxygen-independent coproporphyrinogen-III oxidase (heme biosynthesis)67 2.19 5.12 0.00587
PA1556 ccoO2 Cytochrome c oxidase, cbb3-type, CcoO subunit (energy metabolism, electron transport) 2.40 8.24 0.00587
PA1673 — Probable bacteriohemerythrin (non-heme diiron oxygen transport proteins) 2.43 8.09 0.00587
PA1746 — Unknown function. Orthologue to Appr-1-p (ADP-ribose-1”-monophosphate) processing protein 1,81 5.95 0.00587
PA2753 — Unknown function 1.42 5.09 0.00587
PA3278 — Unknown function 1.26 4.31 0.00587
PA3305.1 phrS Non-coding RNA involved in quorum sensing regulation68 2.79 5.94 0.00587
PA3337 rfaD ADP-L-glycero-D-manno-heptose-6-epimerase 2.38 7.70 0.00587
PA3458 — Probable transcriptional regulator of the MarR family 1.18 3.99 0.00587
PA3880 — Unknown function 2.04 6.30 0.00587
PA4067 oprG Outer membrane porin, transport of cations and small aminoacids69 2.89 6.99 0.00587
PA4159 fepB Ferrienterobactin-binding periplasmic protein70 1.45 5.13 0.00587
PA4348 — Unknown function, contains a metallo-beta-lactamase domain 3.047 9.90 0.00587
PA4358 feoB Fe2+ transporter71 2.51 6.73 0.00587
PA4359 feoA Fe2+ transporter, probable activator of FeoB71 3.57 9.92 0.00587
PA4577 — Unknown function, probable TraR/DksA family transcriptional regulator 1.58 5.40 0.00587
PA4610 — Unknown function, probable copper export protein 1.26 4.48 0.01063
PA5027 dadA Universal stress (UspA)-like protein 2.35 6.25 0.00587
PA5427 adhA Alcohol dehydrogenase 1.95 5.12 0.00587
PA5475 — Unknown function, N-acetyltransferase domain 2.81 7.02 0.00587
PA0676 vreR Anti-σ factor19 −9.79 −19.48 0.00587
PA0878 Unknown function −1.30 −4.21 0.00587
PA2356 msuD Methanesulfonate sulfonatase (sulfur metabolism)72 −1.82 −4.58 0.00587
PA2357 msuE NADH-dependent FMN reductase (sulfur metabolism)72 −2.05 −6.08 0.00587
PA3510 — Unknown function −1.10 −3.85 0.01063
PA4022 hdhA Hydrazone dehydrogenase73 −1.01 −3.57 0.04697
PA4280.2 23 S rRNA74 −3.89 −7.68 0.00587
PA4690.5 16 S rRNA74 −2.08 −5.26 0.00587
PA4690.2 23 S rRNA74 −2.08 −5.54 0.00587
Table 1. Differentially expressed P. aeruginosa genes in ΔvreR versus PAO1a. aSignificant differentially 
expressed genes were obtained by Cufflinks 2.2.1 analyses ref. 60. bT2SS, type II secretion system; TPS, two 
partner secretion; rRNA, ribosomal RNA; tRNA, transfer RNA. cThe (base 2) log of the fold change (FPKM-
ΔvreR/FPKM-PAO1 being FPKM fragments per kilobase per million fragments mapped). dValue of the test 
statistic used to compute significance of the observed change in FPKM ref. 60. eToo many fragments of the pdtA 
mRNA in the ΔvreR sample.
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higher expression of these genes in the ΔvreR mutant directly depends on σVreI. However, the relative expression 
of eight genes that were not previously identified as part of the σVreI regulon (PA0141, ccoO2, PA1673, PA1746, 
PA3880, PA4348, dadA and adhA) was similar in both mutants (Fig. 4). This indicates that the expression of these 
genes is not affected by the absence of σVreI and therefore that this σ factor is not involved in their transcription. 
Finally, the expression of nine other genes (PA0200, ddaR, PA1414, hemN, phrS, rfaD, oprG, feoA and PA5475) 
was higher in the ΔvreI vreR mutant than in ΔvreR (Fig. 4). This suggests that σVreI not only does not mediate 
the transcription of these genes, but also that presence of this σ factor impairs their expression. Overall, this anal-
ysis suggests that VreR has a broader role in gene regulation beyond its direct involvement in the σVreI signaling 
pathway.
σVrei is activated in vivo during infection. To analyze whether σVreI is activated in vivo, we used zebrafish 
embryos and A549 cells as hosts and a σVreI-dependent fluorescent construct in which the promoter of the σVreI 
regulated gene pdtA (Fig. 1) was cloned in front of a red fluorescent protein (rfp) gene (Table S1). P. aeruginosa 
PAO1 and ΔvreI strains were grown in high Pi conditions to avoid σVreI expression and activation prior to infec-
tion19. Bacteria were injected in the hindbrain ventricle of the zebrafish embryos (Fig. 5A) to produce an infection 
that remains initially localized, which facilitates fluorescence measurements. Directly after injection with either 
strain [0 hours post-infection (hpi)], red fluorescence was undetectable, indicating that there was no transcription 
from the σVreI-dependent pdtA promoter and thus that σVreI is not active (Fig. 5B, red channel). At this early infec-
tion point there was no neutrophil recruitment observed inside the hindbrain ventricle (Fig. 5B, green channel). 
However, at 12 hpi embryos injected with the PAO1 wild-type strain or the ΔvreI mutant showed recruitment of 
neutrophils in the head, indicative of an ongoing infection (Fig. 5B, green channel). Importantly, at this time point 
red fluorescence in bacterial aggregates was observed in the embryos infected with the wild-type but not with the 
∆vreI mutant (Fig. 5B, red channel). This shows that pdtA expression occurs during infection in a σVreI-dependent 
manner and therefore suggests that this σ factor is expressed and active in these conditions.
We also analyzed σVreI activation upon interaction of P. aeruginosa with the A549 human lung epithelial cell 
line. Green fluorescence-labelled P. aeruginosa PAO1 and ΔvreI strains bearing the σVreI-dependent pdtA::rfp 
transcriptional fusion were inoculated in A549 cultures. As control, bacteria were also inoculated in cell-free 
cultures. At 0 hpi, red fluorescence in either extracellular or internalized P. aeruginosa cells was undetectable 
(Fig. 6A). However, at 10 hpi red fluorescence was observed in the PAO1 wild-type cells and was considerably 
higher in the A549-containing cultures than in the A549-free cultures (P < 0.01) (Fig. 6A,B). In contrast, fluores-
cence remained undetectable in the ΔvreI mutant independently of the presence or absence of the A549 epithelial 
cells (Fig. 6A). Together this suggests that the expression of pdtA is induced by the presence of the human cells 
and that this induction depends on σVreI. To confirm this result, we measured pdtA expression by qRT-PCR after 
PAO1 inoculation in A549-free and A549-containing cultures. The cycle threshold (ct) value of a total of eight 
Figure 4. Differential gene expression in the P. aeruginosa ΔvreR and ΔvreI vreR mutants. mRNA levels of the 
indicated genes were obtained by qRT-PCR upon growth of the P. aeruginosa mutants in low Pi medium. The  
2−ΔΔCT method was used to determine the fold-change range in gene expression in ΔvreI vreR versus ΔvreR. 
Data are means ± SD from three biological replicates (N = 3) each one including three technical replicates. 
P-values were calculated by one-sample t-test to a hypothetical value of 1 as described in Materials and Methods.
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biologically independent co-incubations was determined (Fig. 7). In A549-containing cultures the expression of 
pdtA increased between 3- and 40-fold compared to the cell-free cultures (Fig. 7). This confirms that expression 
of pdtA is induced upon contact of P. aeruginosa with the eukaryotic cell. Altogether, these results indicate that 
σVreI is active during infection.
Discussion
Pi starvation has been described as an important signal for pathogens and indeed Pi amounts are partially linked 
to the immune status of the host. During major surgical operations and also in patients with severe burns, the 
reabsorption of Pi by the kidneys is reduced and exudative losses are higher than normal leading to hypophos-
phatemia, which can intensify upon treatments with bisphosphonates or antivirals32–34. During respiratory alka-
losis caused by sepsis or mechanical respiration, a redistribution of the Pi into cells occurs and this reduces 
the extracellular content of Pi35. Increased levels of circulating catecholamines, which occurs in CF patients36, 
has been also associated with hypophosphatemia35. Evolution has benefited pathogens that are able to recognize 
and react to this marker37, thus exploiting the lower activity of the host immune system in this condition38. P. 
aeruginosa recognizes low Pi environments through the phosphate-specific ABC transport Pst system, which 
in Pi limiting conditions transports phosphate and triggers activation of the PhoR/PhoB two-component sys-
tem37. Activated PhoR histidine kinase phosphorylates the transcriptional response regulator PhoB, which in 
turn promotes expression of the so-called pho regulon that in P. aeruginosa comprises several virulence factors37. 
In accordance, Pi starvation enhances P. aeruginosa virulence in zebrafish embryos (Fig. 2A), as also observed in 
mice and nematodes24,39–41, whereas excess of Pi reduces virulence (Fig. 2A). The pho regulon includes the vreAIR 
operon and the σVreI regulon (Fig. 1)19, and we have shown here that ΔvreI and ΔvreR mutations impair the low 
Pi-induced P. aeruginosa virulence (Figs. 2B and 3). Although the attenuated virulence of the ΔvreI mutant could 
be due to the lack of vreR expression in this mutant19, its phenotype is in line with previous results showing that 
overproduction of σVreI considerably increases P. aeruginosa pathogenicity21. In fact, it was surprising to find that 
the absence of the anti-σ factor VreR also led to attenuated virulence, despite the fact that σVreI is considerably 
active in the ΔvreR mutant19. Our transcriptomic and qRT-PCR analyses have revealed that VreR influences gene 
expression not only in a σVreI-dependent but also in a σVreI-independent manner. This includes several functions 
that could affect P. aeruginosa virulence (e.g. the PA0141/PPK2 required for alginate synthesis, the non-coding 
phrS RNA involved in quorum sensing regulation, the universal stress response dadA), and several regulators of 
gene expression (e.g. ddaR, PA3458/MarR-like regulator, PA4577/DksA-like regulator) (Table 1). How VreR mod-
ulates gene expression independently of σVreI is at present unknown but likely involves some of these regulatory 
proteins. In contrast, the third component of the operon, VreA, does not seem to play a role in the low Pi-induced 
virulence of P. aeruginosa. In fact, VreA does not seem to be involved in σVreI activation either in vitro19 or in vivo 
(Fig. 2B), which suggests that the σVreI/VreR signaling cascade does not require this protein.
Furthermore, we have shown in this work that σVreI is active in vivo during infection. pdtA expression, which 
in vitro completely depends on the σVreI/VreR signaling cascade and the PhoB regulator19, occurs during P. 
Figure 5. σVreI activation during P. aeruginosa infection in zebrafish embryos. (A) Dorsal view of the head 
of a two days post-fertilization zebrafish embryo. The hindbrain ventricle where P. aeruginosa was injected is 
highlighted. (B) Confocal images of the head of embryos injected in the hindbrain ventricle with ∼2000 CFU 
of the P. aeruginosa PAO1 wild-type strain or its isogenic ΔvreI mutant bearing the σVreI-dependent pdtA::rfp 
transcriptional fusion (pMP0690mCherry plasmid, Table S1) (red channel) at 0 and 12 hpi. P. aeruginosa was 
grown in high Pi medium prior injection. Neutrophils expressing constitutively a green fluorescence protein 
(gfp) are also visualized (green channel). Images are representative of three independent experiments (N = 3).
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Figure 6. Activation of σVreI upon interaction of P. aeruginosa with A549 eukaryotic cells. (A) Confocal images 
of P. aeruginosa-A549 co-cultures at 0 and 10 hpi. P. aeruginosa PAO1 wild-type strain and its isogenic ∆vreI 
mutant expressing a green fluorescent protein (gfp) constitutively (from the pBBRmEos3.1 plasmid, Table S1) 
(green channel) and containing the σVreI-dependent pdtA::rfp transcriptional fusion (pMP0690mCherry 
plasmid, Table S1) (red channel) were grown in high Pi medium and inoculated in A549-containing and 
A549-free cultures. A549 cells DNA was stained with DAPI (blue channel). Images are representative of three 
independent experiments (N = 3). (B) Quantification of the red fluorescence intensity observed in (A) was 
performed as described in Materials and Methods, and the total corrected cellular fluorescence (TCCF) is given. 
Data are means ± SD from three biological replicates (N = 3). P-value was calculated by unpaired two-tailed 
t-test.
Figure 7. pdtA mRNA levels upon P. aeruginosa interaction with A549 cells. The P. aeruginosa PAO1 wild-
type strain was grown in high Pi medium and inoculated in A549-containing and A549-free cultures. At 3 
hpi, total RNA was extracted and pdtA mRNA levels determined by qRT-PCR. Data plotted are the result of 
eight biologically independent replicates, each bar representing means ± SD of the three technical replicates 
performed on each biological replicate. The cycle threshold (ct) average and the standard deviation (SD) of each 
condition is indicated. The 2−ΔΔCT method was used to determine the fold-change range in pdtA expression in 
A549-containing versus A549-free cultures. The fold-change range taking into account the SD is shown between 
brackets.
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aeruginosa infections in zebrafish embryos and upon interaction with human epithelial cells, and in these in vivo 
situations expression of pdtA also completely depends on σVreI. The activation of σVreI in vivo is in accordance with 
the increased expression of the vreAIR operon and the σVreI regulon (including pdtA) in mouse models of acute 
and chronic infections42, and with the presence of antibodies against the PdtA protein in the serum of P. aerugi-
nosa infected patients21. Presence of an active σVreI protein requires Pi limitation conditions in order for vreI to be 
expressed. However, the σVreI inhibitor, the VreR anti-σ factor, is also expressed in this condition19. A basal activity 
of σVreI is observed under Pi limitation; however, maximal activity of this σ factor requires the removal of VreR19. 
Because activation of P. aeruginosa σECF factors in response to the inducing signal usually occurs through the reg-
ulated proteolysis of the anti-σ factor12–15, another signal is expected to be required for complete σVreI activation. 
The signal could be host-derived, as described for the σV factor of the opportunistic pathogens Clostridioides diffi-
cile and Enterococcus faecalis, which is activated by lysozyme, an important component of the innate immune sys-
tem of many organisms43. Alternatively, the activating signal could be produced by P. aeruginosa itself in response 
to the host environment. An example of such a mechanism is the activation of σPvdS in P. aeruginosa, which in 
response to the iron starvation conditions encountered in the host44,45 produces pyoverdine that in turn increases 
σPvdS activation and P. aeruginosa virulence46,47. Another example is the activation of the P. aeruginosa σAlgT factor 
in response to the oxidative stress generated by the oxygen radicals produced by leucocytes or in response to the 
elevated temperatures that are often produced in infected hosts48,49. Both situations lead to cell envelope stress 
and the accumulation of misfolded proteins in the bacterial periplasm, which trigger σAlgT activation50. Further 
research will be conducted to clarify how activation of σVreI in response to the host occurs.
Methods
Bacterial strains and growth conditions. Strains used are listed in Table S1. Bacteria were routinely 
grown in Luria-Bertani (LB) medium51 at 37 °C in a rotary shaker at 200 rpm. For differential expression of the 
vreAIR operon low and high phosphate media were used19. When necessary, antibiotics (Sigma-Aldrich) were 
used at the following final concentrations (μg ml−1): ampicillin (Ap), 100; gentamicin (Gm), 20; hygromycin B 
(Hg), 100; nalidixic (Nal), 10; and tetracycline (Tc), 20.
plasmids construction and molecular biology. Plasmids used are described in Table S1 and primers 
listed in Table S2 and S3. PCR amplifications were performed using Phusion® Hot Start High-Fidelity DNA 
Polymerase (Finnzymes). All constructs were confirmed by DNA sequencing and transferred to P. aeruginosa by 
electroporation52.
Zebrafish maintenance, embryo care and infection procedure. Transparent adult casper mutant 
zebrafish (mitfaw2/w2; roya9/a9) and adult labelled Tg(mpx:GFP)i114 casper zebrafish producing green fluorescent 
neutrophils53,54 were maintained at 26 °C in aerated 5 L tanks with a 10/14 h dark/light cycle. Zebrafish embryos 
were collected during the first hour post-fertilization (hpf) and kept at 28 °C in E3 medium (5.0 mM NaCl, 
0.17 mM KCl, 0.33 mM CaCl·2H2O, 0.33 mM MgCl2·6H2O) supplemented with 0.3 mg/L methylene blue. Prior 
to infection, 1 or 2 days post-fertilization (dpf) embryos were mechanically dechorionated and anaesthetized in 
0.02% (w/v) buffered 3-aminobenzoic acid methyl ester (pH 7.0) (Tricaine, Sigma-Aldrich). Zebrafish embryos 
were individually infected by microinjection with 1 nl of P. aeruginosa either in the hindbrain ventricle (localized 
infection) or in the caudal vein (systemic infection) as described elsewhere26,55. All procedures involving zebrafish 
embryos were according to local animal welfare regulations and in accordance with the EU Animal Protection 
Directive 86/609 EEC.
Virulence assay in infected zebrafish embryos. Zebrafish embryos were injected in the caudal vein 
with ∼1000 colony forming units (CFU) of exponentially grown P. aeruginosa cells in low or high phosphate con-
ditions previously resuspended in phosphate-free physiological salt containing 0.5% (w/v) of phenol red. After 
infection, embryos were kept in 6-well plates containing 60 μg/mL of Sea salts (Sigma-Aldrich) at 32 °C with 20 
individually injected embryos in each group per well. Embryo survival was determined by monitoring live and 
dead embryos at fixed time points during five days. Four biologically independent experiments were performed 
and the data given are the average. P-values were calculated by log-rank (Mantel-Cox) test.
confocal fluorescence imaging of zebrafish embryos. For confocal imaging, zebrafish embryos 
were injected in the hindbrain ventricle with ∼2000 CFU of P. aeruginosa cells containing a σVreI-dependent 
red fluorescence transcriptional fusion. At 0 and 12 hpi, embryos were fixated overnight in 4% (v/v) paraform-
aldehyde in phosphate buffered saline (PBS). Before imaging, fixated embryos were embedded in 1.5% (w/v) 
low-melting-point agarose using an open uncoated 8-well microscopy µ-slide (Ibidi®). Confocal images were 
generated with a Leica TCS SP8 Confocal Microscope. Leica Application Suite X and ImageJ software was used 
to process the confocal images, specifically for brightness/contrast enhancements as well as for creating merged 
images.
Cytotoxicity assay in A549 human lung epithelial cells. P. aeruginosa cytotoxicity on A549 cells was 
assayed using a colorimetric assay that detects the number of metabolically active eukaryotic cells able to cleave 
the MTT tetrazolium salt (Sigma-Aldrich) to the insoluble formazan dye. The A549 cell line (ATCC® CCL-
185™) was maintained in Dulbecco’s Modified Eagle Medium (DMEM) medium supplemented with 10% (v/v) 
fetal bovine serum (FBS) (Gibco) in a 5% CO2 incubator at 37 °C. One day prior to infection, the A549 cells were 
placed in 96-well plates at a concentration of 4 ×104 cells/well and cultured in phosphate-free DMEM medium 
(Gibco) with 5% (v/v) FBS. In this condition, cell mitosis does almost not occur. Late exponentially grown P. 
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aeruginosa strains in low or high phosphate conditions were then inoculated at a multiplicity of infection (MOI) 
of 20. At 3 hpi, 30 μl of a 5 mg/ml MTT solution in PBS was added to the wells and the plates were incubated for 
2 h. The culture medium was then removed and 100 μl of dimethyl sulfoxide (DMSO) was added to solubilize the 
formazan. Production of formazan, which directly correlates to the number of viable cells, was quantified using a 
scanning multi-well spectrophotometer (Infinite® 200 PRO Tecan) at 620 nm.
Confocal fluorescence imaging of A549 cells. For confocal imaging, 2 ×105 A549 cells were seeded 
in 24-well plates containing 11 mm round glass coverslips and phosphate-free DMEM medium with 5% (v/v) 
FBS one day prior to infection. Infections with green fluorescence-labelled P. aeruginosa cells containing a 
σVreI-dependent red fluorescence transcriptional fusion were performed at a MOI of 10. At 0 and 10 hpi, the 
cells were fixated with 4% (v/v) paraformaldehyde in PBS. Samples were washed with PBS and coverslips were 
mounted on glass slides containing Fluoroshield mounting medium with DAPI (Sigma-Aldrich) to retain fluores-
cence and stain the A549 cells DNA. Confocal images were generated with a Nikon A1R confocal scanning laser 
microscope. NIS-Elements and ImageJ software were used to process the confocal images. Total corrected cellular 
fluorescence (TCCF) was calculated using the following equation: TCCF = integrated density − (area of selected 
cell × mean fluorescence of background readings), as described before56,57.
internalization assay. To enumerate bacteria internalized into A549 cells, a polymyxin B protection assay 
was performed with P. aeruginosa strains grown at late exponential phase in low phosphate conditions. A549 
cells were cultured in 24-well plates at a concentration of 2 ×105 cells/well in phosphate-free DMEM medium 
supplemented with 5% (v/v) FBS. Bacterial infections were performed at a MOI of 10. At 6 hpi, the culture super-
natants were collected and serial dilutions plated on LB for bacterial counting. Fresh DMEM medium containing 
20 μg/ml polymyxin B was added to the infection wells and incubated during 45 min to kill extracellular bacteria. 
Afterward, the antibiotic-containing medium was removed and the cells were lysed with 1% (v/v) Triton X-100 
(Sigma-Aldrich) in PBS during 10 min. Serial dilution of the lysed cells were plated on LB for bacterial counting. 
Internalization is reported as the ratio between the CFU after the lysis of the A549 cells and CFU in the culture 
supernatant.
RnA isolation. Total RNA was extracted by the hot phenol method using the TRI® Reagent protocol 
(Ambion) as described elsewhere58 and subjected to two DNase I treatments with the Turbo DNA-free kit 
(Ambion) and RNaseOUT (Invitrogen). RNA quality, including purity, integrity and yield, was assessed by elec-
trophoresis of 1 µg of total RNA and by UV absorption at 260 nm in a ND-1000 spectrophotometer (NanoDrop 
Technologies, USA).
Quantitative Rt-pcR analyses. A549 cells cultured in 6-well plates in phosphate-free DMEM medium 
with 5% (v/v) FBS were infected with exponentially grown P. aeruginosa cells in high phosphate conditions at a 
MOI of 10. At 3 hpi, the culture supernatants were spun down at 1600 × g and 4 °C and total RNA was isolated. 
cDNA from eight biologically independent replicates was produced in triplicate by reverse transcription reac-
tions of 0.5–1 µg RNA using SuperScript II reverse transcriptase (Invitrogen) and random hexamers as primers 
according to the protocol supplied. Real-time PCR amplifications were carried out on a MyiQ2 system (Bio-Rad) 
associated with iQ5 optical system software (version 2.1.97.1001) in 11.5 µl reaction mixture containing 6.25 µl 
of iQ SYBR green Supermix (Bio-Rad), 0.4 µM of each primer (Table S2) and 1 µl of the template cDNA (diluted 
1000-fold when measuring the 16S rRNA reference gene). Thermal cycling conditions were the following: one 
cycle at 95 °C for 10 min and then 40 cycles at 95 °C for 15 s, 65 °C for 30 s, and 72 °C for 20 s, with a single fluo-
rescence measurement per cycle according to the manufacturers’ recommendations. Melting curve analyses were 
performed by gradually heating the PCR mixture from 55 to 95 °C at a rate of 0.5 °C per 10 s for 80 cycles. The 
relative expression of the genes was normalized to that of 16 S rRNA and the results were analyzed by means of 
the comparative cycle threshold (∆∆ct) method59.
RnA-seq analysis. P. aeruginosa PAO1 and its isogenic ΔvreR mutant were grown until late exponential 
phase in low Pi medium and total RNA was isolated. A mixture of the three isolations was used for RNA-seq 
analyses, which were performed at Era7 Bioinformatics (Granada, Spain). First, the rRNA from 4 µg of total RNA 
was removed using the Ribo-Zero rRNA removal kit (Illumina) following the manufactures’ recommendations. 
Sequencing libraries were prepared with the NEBNext Ultra directional RNA library Prep kit (New England 
Biolabs). RNA was fragmented at 94 °C for 7.5 min and first strand cDNA synthesis was performed at 42 °C during 
50 min using the adaptor and primers recommended by the manufacturer (NEBNext Multiplex Oligos, Illumina). 
Samples were then processed on the Illumina NextSeq. 500 Sequencer in one run with a read length of 2 × 75 bp. 
The pipeline recommended in the tool Cufflinks 2.2.160 was used to analyze the data and obtain the set of differ-
entially expressed genes following these steps: 1) Raw reads quality analysis with the tool FastQC (http://www.
bioinformatics.babraham.ac.uk/projects/fastqc); 2) Reads mapping to the P. aeruginosa PAO1 reference genome 
(NCBI reference sequence NC_002516.2) with the tool Bowtie integrated in the Tophat suite61; and 3) analysis of 
differences in gene expression with Cufflinks 2.2.160. All the samples passed the quality analysis. Tests related to 
overrepresented sequences failed in some of the samples (corresponding to overexpressed genes in this case, e.g. 
pdtA, Table 1). Significant differentially expressed genes depending on whether P is greater than the false discov-
ery rate (FDR) after Benjamini-Hochberg correction for multiple-testing (as indicated in the Cufflinks 2.2.1 tool) 
are shown in Table 1. P-value is below 0.0001 in all cases. RNA-seq data set have been deposited in NCBI’s Gene 
Expression Omnibus (GEO) database under accession number GSE122253 (https://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE122253). RNA-seq results were confirmed by qRT-PCR using RNA from three biological 
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replicates obtained from P. aeruginosa cells grown in the same conditions that for the RNA-seq assay and primers 
listed in Table S2.
other bioinformatics analyses. Statistical analyses are based on t-test in which two conditions are com-
pared independently. P-values from raw data were calculated by independent two-tailed t-test and from ratio data 
to the control by one-sample t-test using GRAPHPAD PRISM version 5.01 for Windows and are represented in 
the graphs by ns, non-significant; *P < 0.05; **P < 0.01; and ***P < 0.001.
Data availability
The RNA-seq data set is openly available in NCBI’s Gene Expression Omnibus (GEO) database under accession 
number GSE122253 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE122253).
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